Prostate cancer patients
Clinical trials for Prostate cancer patients explained in plain language.
Never miss a new study
Get alerted when new Prostate cancer patients trials appear
Sign up with your email to follow new studies for Prostate cancer patients, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a Triple-Drug cocktail before surgery curb prostate Cancer's return?
Disease control Not yet recruitingThis trial tests whether adding darolutamide to standard chemotherapy and hormone therapy before prostate removal can improve long-term outcomes for men with locally advanced prostate cancer. Participants receive either the triple combination or the standard two-drug regimen for …
Matched conditions: PROSTATE CANCER PATIENTS
Phase 2 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Combination therapy aims to wipe out High-Risk prostate cancer before surgery
Disease control Not yet recruitingThis trial investigates whether combining a targeted radioactive drug (177Lu-PSMA-617) with a hormone therapy (darolutamide) before surgery can improve outcomes for men with high-risk localized prostate cancer. Participants receive two doses of the radioactive drug and daily horm…
Matched conditions: PROSTATE CANCER PATIENTS
Phase 4 • Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a nurse coach couples back to intimacy after prostate cancer?
Symptom relief Not yet recruitingResearchers are testing a six-week, nurse-led program that helps Chinese prostate cancer survivors and their female partners talk about sex, rebuild intimacy, and cope together after treatment. About 72 couples join the study, with half receiving the program plus standard survivo…
Matched conditions: PROSTATE CANCER PATIENTS
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 21, 2026 13:00 UTC
-
AI chatbot aims to demystify prostate cancer radiation — a trial puts it to the test
Symptom relief Not yet recruitingThis trial tests whether an artificial intelligence chatbot can help men with prostate cancer better understand radiation therapy. Participants will use a plain-language chatbot alongside standard education from their care team. Researchers will measure changes in patients' confi…
Matched conditions: PROSTATE CANCER PATIENTS
Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Sep 19, 2026 00:00 UTC
-
Exercise may counteract side effects of prostate cancer hormone therapy
Symptom relief Not yet recruitingThis trial investigates whether a supervised program of aerobic and strength training can improve quality of life, heart function, and body composition in men with prostate cancer who are receiving androgen deprivation therapy (hormone therapy). The study involves 46 men aged 40 …
Matched conditions: PROSTATE CANCER PATIENTS
Sponsor: Universidade Federal de Santa Catarina • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Yoga from home: new study tests if digital classes ease prostate cancer side effects
Symptom relief Not yet recruitingThis study will test whether an internet-based yoga program can help men with prostate cancer manage stress, urinary problems, and quality of life. 220 men who have been treated for prostate cancer will be randomly assigned to either the digital yoga program or standard care. The…
Matched conditions: PROSTATE CANCER PATIENTS
Sponsor: Region Örebro County • Aim: Symptom relief
Last updated Jun 26, 2026 13:46 UTC
-
Can a digital guide boost genetic testing in prostate cancer survivors?
Knowledge-focused Not yet recruitingThis study looks at the best way to help prostate cancer survivors learn about and get genetic testing for inherited cancer risks. About 500 participants will be randomly assigned to a digital guide, a printed guide, or standard care. Researchers will track who requests testing a…
Matched conditions: PROSTATE CANCER PATIENTS
Sponsor: Georgetown University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Could a lower dose of enzalutamide work better for elderly prostate cancer patients?
Knowledge-focused Not yet recruitingThis phase 2 trial is testing four different doses of enzalutamide (40, 80, 120, and 160 mg) in men aged 75 and older with advanced prostate cancer. The goal is to see how drug levels in the blood differ between older and younger patients, and to find the safest and most effectiv…
Matched conditions: PROSTATE CANCER PATIENTS
Phase 2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC